We’re pleased that abiraterone can now be offered to thousands more men affected by prostate cancer. Read more about this decision and what it means: cruk.ink/3LzxTbS
January 17, 2026 at 2:34 PM
We’re pleased that abiraterone can now be offered to thousands more men affected by prostate cancer. Read more about this decision and what it means: cruk.ink/3LzxTbS
Cc: @ianmsanders.bsky.social
Prostate drug, abiraterone, to be offered to thousands in England - BBC News share.google/cdR0QUbQoO05...
Prostate drug, abiraterone, to be offered to thousands in England - BBC News share.google/cdR0QUbQoO05...
Prostate drug, abiraterone, to be offered to thousands in England
Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.
share.google
January 16, 2026 at 7:29 PM
Cc: @ianmsanders.bsky.social
Prostate drug, abiraterone, to be offered to thousands in England - BBC News share.google/cdR0QUbQoO05...
Prostate drug, abiraterone, to be offered to thousands in England - BBC News share.google/cdR0QUbQoO05...
👏 We’re delighted that NHS England will now offer abiraterone to men with high-risk non-metastatic #ProstateCancer.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
January 16, 2026 at 6:14 PM
👏 We’re delighted that NHS England will now offer abiraterone to men with high-risk non-metastatic #ProstateCancer.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
Discovered over 30 years ago in the labs of the ICR, abiraterone has transformed prostate cancer treatment worldwide.
Thousands more men in England offered abiraterone, one of our prostate cancer treatment breakthroughs
news.cancerresearchuk.org/2026/01/16/t...
news.cancerresearchuk.org/2026/01/16/t...
Thousands more men in England offered abiraterone, one of our prostate cancer treatment breakthroughs - Cancer Research UK - Cancer News
The NHS in England will now use abiraterone, a drug we developed, to treat high-risk, hormone-sensitive prostate cancer that hasn’t spread.
news.cancerresearchuk.org
January 17, 2026 at 7:06 AM
Thousands more men in England offered abiraterone, one of our prostate cancer treatment breakthroughs
news.cancerresearchuk.org/2026/01/16/t...
news.cancerresearchuk.org/2026/01/16/t...
A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks.
Abiraterone has been provided on the NHS in Scotland and Wales since 2023 but not in England and Northern Ireland, except in the most severe cases.
www.bbc.co.uk/news/article...
Abiraterone has been provided on the NHS in Scotland and Wales since 2023 but not in England and Northern Ireland, except in the most severe cases.
www.bbc.co.uk/news/article...
Prostate drug, abiraterone, to be offered to thousands in England
Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.
www.bbc.co.uk
January 16, 2026 at 6:05 PM
A life-extending prostate cancer drug is to be made available to thousands of men in England in a matter of weeks.
Abiraterone has been provided on the NHS in Scotland and Wales since 2023 but not in England and Northern Ireland, except in the most severe cases.
www.bbc.co.uk/news/article...
Abiraterone has been provided on the NHS in Scotland and Wales since 2023 but not in England and Northern Ireland, except in the most severe cases.
www.bbc.co.uk/news/article...
Prostate drug, abiraterone, to be offered
I was treated with arbiraterone for 24 months
It intensifies castration from zoladex
Believe me: a very powerful drug but immense negative side effects
Discuss with your oncologist and monitor health & quality of life
www.bbc.co.uk/news/article...
I was treated with arbiraterone for 24 months
It intensifies castration from zoladex
Believe me: a very powerful drug but immense negative side effects
Discuss with your oncologist and monitor health & quality of life
www.bbc.co.uk/news/article...
Prostate drug, abiraterone, to be offered to thousands in England
Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.
www.bbc.co.uk
January 16, 2026 at 6:55 PM
Prostate drug, abiraterone, to be offered
I was treated with arbiraterone for 24 months
It intensifies castration from zoladex
Believe me: a very powerful drug but immense negative side effects
Discuss with your oncologist and monitor health & quality of life
www.bbc.co.uk/news/article...
I was treated with arbiraterone for 24 months
It intensifies castration from zoladex
Believe me: a very powerful drug but immense negative side effects
Discuss with your oncologist and monitor health & quality of life
www.bbc.co.uk/news/article...
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
@fda.gov
oncodaily.com/fda-approval...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Niraparib #Abiraterone #BRCA2 #ProstateCancer #MCSPC
@fda.gov
oncodaily.com/fda-approval...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Niraparib #Abiraterone #BRCA2 #ProstateCancer #MCSPC
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer - OncoDaily
FDA approves niraparib plus abiraterone and prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer based on AMPLITUDE trial data.
oncodaily.com
December 16, 2025 at 10:47 PM
FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer
@fda.gov
oncodaily.com/fda-approval...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Niraparib #Abiraterone #BRCA2 #ProstateCancer #MCSPC
@fda.gov
oncodaily.com/fda-approval...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #Niraparib #Abiraterone #BRCA2 #ProstateCancer #MCSPC
Great news for AKT inhibitors! Capivasertib in combo with abiraterone and ADT improves progression free survival in PTEN deficient prostate cancer! Anticipating approval for this combo, coming off the approval of capi in ER+be breast cancer. Good work AZ!
www.onclive.com/view/capivas...
www.onclive.com/view/capivas...
Capivasertib Plus Abiraterone/ADT Improves rPFS in PTEN-Deficient mHSPC
Capivasertib plus abiraterone and ADT improved rPFS in PTEN-deficient metastatic hormone-sensitive prostate cancer.
www.onclive.com
November 26, 2024 at 5:45 PM
Great news for AKT inhibitors! Capivasertib in combo with abiraterone and ADT improves progression free survival in PTEN deficient prostate cancer! Anticipating approval for this combo, coming off the approval of capi in ER+be breast cancer. Good work AZ!
www.onclive.com/view/capivas...
www.onclive.com/view/capivas...
Prostate drug, abiraterone, to be offered to thousands in England
https://www.europesays.com/ie/290646/
Hugh Pym,Health editorand Ian Atkinson Giles Turner Giles Turner paid privately to access abiraterone and was part of…
https://www.europesays.com/ie/290646/
Hugh Pym,Health editorand Ian Atkinson Giles Turner Giles Turner paid privately to access abiraterone and was part of…
Prostate drug, abiraterone, to be offered to thousands in England - Ireland
Hugh Pym,Health editorand
www.europesays.com
January 18, 2026 at 10:00 AM
Prostate drug, abiraterone, to be offered to thousands in England
https://www.europesays.com/ie/290646/
Hugh Pym,Health editorand Ian Atkinson Giles Turner Giles Turner paid privately to access abiraterone and was part of…
https://www.europesays.com/ie/290646/
Hugh Pym,Health editorand Ian Atkinson Giles Turner Giles Turner paid privately to access abiraterone and was part of…
Life-extending prostate cancer drug to be offered to thousands in England: Abiraterone, a life-extending prostate cancer drug, will soon be available to thousands of men in England on the NHS, a significant victory following a campaign by Prostate Cancer UK and patien… https://ranked.news/137026?u=b
January 17, 2026 at 6:03 AM
Life-extending prostate cancer drug to be offered to thousands in England: Abiraterone, a life-extending prostate cancer drug, will soon be available to thousands of men in England on the NHS, a significant victory following a campaign by Prostate Cancer UK and patien… https://ranked.news/137026?u=b
HealthMatters: This is extremely sad and more or less tells us where were at with the #NHS in England!
#MensHealth #Cancer #ProstateCancer #Prostate #abiraterone #SymeBros
www.bbc.co.uk/news/article...
#MensHealth #Cancer #ProstateCancer #Prostate #abiraterone #SymeBros
www.bbc.co.uk/news/article...
Men denied life-extending prostate cancer drug on NHS in England
NHS England says it cannot afford to offer abiraterone, which is available in Scotland and Wales.
www.bbc.co.uk
March 18, 2025 at 2:25 AM
HealthMatters: This is extremely sad and more or less tells us where were at with the #NHS in England!
#MensHealth #Cancer #ProstateCancer #Prostate #abiraterone #SymeBros
www.bbc.co.uk/news/article...
#MensHealth #Cancer #ProstateCancer #Prostate #abiraterone #SymeBros
www.bbc.co.uk/news/article...
Very excited our story on a CYP17A1-independent androgen biosynthesis pathway is out! Could explain why androgens are left when we use abiraterone to block CYP17A1 clinically in prostate cancer. Need to look more closely at oxidized forms of cholesterol! Please read the whole paper. 🧪 rdcu.be/eS7kU
December 4, 2025 at 12:23 PM
Very excited our story on a CYP17A1-independent androgen biosynthesis pathway is out! Could explain why androgens are left when we use abiraterone to block CYP17A1 clinically in prostate cancer. Need to look more closely at oxidized forms of cholesterol! Please read the whole paper. 🧪 rdcu.be/eS7kU
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment.
www.nature.com/articles/s41...
Results suggest that SBRT may be a viable option for treating omCRPC after progression compared to systemic therapy
www.nature.com/articles/s41...
Results suggest that SBRT may be a viable option for treating omCRPC after progression compared to systemic therapy
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)...
Prostate Cancer and Prostatic Diseases - Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A...
www.nature.com
March 10, 2025 at 12:15 PM
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment.
www.nature.com/articles/s41...
Results suggest that SBRT may be a viable option for treating omCRPC after progression compared to systemic therapy
www.nature.com/articles/s41...
Results suggest that SBRT may be a viable option for treating omCRPC after progression compared to systemic therapy
Really shameful that more than 2 years after we learned that Abiraterone, an inexpensive medicine, saves lives, it is STILL not available in the English NHS. Thanks @prostatecanceruk.bsky.social for highlighting the struggle many men, and their doctors, are facing.
www.bbc.com/news/article...
www.bbc.com/news/article...
www.bbc.com
March 14, 2025 at 8:58 PM
Really shameful that more than 2 years after we learned that Abiraterone, an inexpensive medicine, saves lives, it is STILL not available in the English NHS. Thanks @prostatecanceruk.bsky.social for highlighting the struggle many men, and their doctors, are facing.
www.bbc.com/news/article...
www.bbc.com/news/article...
A question on #Abiraterone tabled by Lord Taylor of Warwick on 03-06-2025 has been answered by Baroness Merron. https://questions-statements.parliament.uk/written-questions/detail/2025-06-03/HL8078
June 20, 2025 at 11:20 AM
A question on #Abiraterone tabled by Lord Taylor of Warwick on 03-06-2025 has been answered by Baroness Merron. https://questions-statements.parliament.uk/written-questions/detail/2025-06-03/HL8078
ICYMI - interesting results from STAMPEDE, presenting an AI tool to predict which men with prostate cancer will benefit most from treatment with abiraterone, offering a more cost-effective approach. Co-led by our faculty member Prof Gert Attard @uclmedsci.bsky.social.
www.ucl.ac.uk/news/2025/ma...
www.ucl.ac.uk/news/2025/ma...
AI test to determine best prostate cancer treatment could save lives and money
A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from U...
www.ucl.ac.uk
July 2, 2025 at 10:31 AM
ICYMI - interesting results from STAMPEDE, presenting an AI tool to predict which men with prostate cancer will benefit most from treatment with abiraterone, offering a more cost-effective approach. Co-led by our faculty member Prof Gert Attard @uclmedsci.bsky.social.
www.ucl.ac.uk/news/2025/ma...
www.ucl.ac.uk/news/2025/ma...
Prostate treatment drug abiraterone to be made available to thousands of people in the UK
hugh pym,health editorand Ian Atkinson Giles Turner Giles Turner personally paid for access to abiraterone and was part of a campaign to get it approved in the UK A life-saving prostate cancer drug will be…
hugh pym,health editorand Ian Atkinson Giles Turner Giles Turner personally paid for access to abiraterone and was part of a campaign to get it approved in the UK A life-saving prostate cancer drug will be…
Prostate treatment drug abiraterone to be made available to thousands of people in the UK
hugh pym,health editorand Ian Atkinson Giles Turner Giles Turner personally paid for access to abiraterone and was part of a campaign to get it approved in the UK A life-saving prostate cancer drug will be made available to thousands of men in the UK within weeks following a campaign by patients and charities. Abiraterone has been available on the NHS in Scotland and Wales since 2023, but is not available in all but the most serious cases in England and Northern Ireland. The drug is being prescribed in the UK to patients with very advanced prostate cancer that has already metastasized.
yojanasewa.com
January 16, 2026 at 7:01 PM
Prostate treatment drug abiraterone to be made available to thousands of people in the UK
hugh pym,health editorand Ian Atkinson Giles Turner Giles Turner personally paid for access to abiraterone and was part of a campaign to get it approved in the UK A life-saving prostate cancer drug will be…
hugh pym,health editorand Ian Atkinson Giles Turner Giles Turner personally paid for access to abiraterone and was part of a campaign to get it approved in the UK A life-saving prostate cancer drug will be…
Just a reminder that when you give (or take) abiraterone for prostate cancer, you get a bunch of complex steroidal metabolites with various activities. It is messy. Below is what occurs after a single dose. 🧪
www.jci.org/articles/vie...
www.jci.org/articles/vie...
March 21, 2025 at 12:41 PM
Just a reminder that when you give (or take) abiraterone for prostate cancer, you get a bunch of complex steroidal metabolites with various activities. It is messy. Below is what occurs after a single dose. 🧪
www.jci.org/articles/vie...
www.jci.org/articles/vie...
And here I am, diligently taking my niraparib and abiraterone acetate - I'm such a sucker, I should put more coffee up my ass.
June 2, 2025 at 9:57 PM
And here I am, diligently taking my niraparib and abiraterone acetate - I'm such a sucker, I should put more coffee up my ass.